Australia markets closed

CONMED Corporation (CNMD)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
65.78+3.88 (+6.27%)
At close: 04:00PM EDT
65.78 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.03B
Enterprise value 2.98B
Trailing P/E 25.20
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.65
Price/book (mrq)2.37
Enterprise value/revenue 2.36
Enterprise value/EBITDA 13.88

Trading information

Stock price history

Beta (5Y monthly) 1.34
52-week change 3-47.73%
S&P500 52-week change 322.36%
52-week high 3138.47
52-week low 361.05
50-day moving average 378.13
200-day moving average 398.75

Share statistics

Avg vol (3-month) 3609.74k
Avg vol (10-day) 3912.75k
Shares outstanding 530.8M
Implied shares outstanding 634.83M
Float 830.53M
% held by insiders 10.54%
% held by institutions 1119.23%
Shares short (15 Apr 2024) 43.89M
Short ratio (15 Apr 2024) 48.08
Short % of float (15 Apr 2024) 417.55%
Short % of shares outstanding (15 Apr 2024) 412.65%
Shares short (prior month 15 Mar 2024) 43.93M

Dividends & splits

Forward annual dividend rate 40.8
Forward annual dividend yield 41.22%
Trailing annual dividend rate 30.80
Trailing annual dividend yield 31.29%
5-year average dividend yield 40.79
Payout ratio 430.65%
Dividend date 305 Apr 2024
Ex-dividend date 414 Mar 2024
Last split factor 23:2
Last split date 310 Sept 2001

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 6.53%
Operating margin (ttm)9.63%

Management effectiveness

Return on assets (ttm)3.68%
Return on equity (ttm)10.25%

Income statement

Revenue (ttm)1.26B
Revenue per share (ttm)41.05
Quarterly revenue growth (yoy)5.70%
Gross profit (ttm)N/A
EBITDA 206.55M
Net income avi to common (ttm)82.35M
Diluted EPS (ttm)2.61
Quarterly earnings growth (yoy)983.50%

Balance sheet

Total cash (mrq)33.85M
Total cash per share (mrq)1.1
Total debt (mrq)990.8M
Total debt/equity (mrq)115.93%
Current ratio (mrq)2.18
Book value per share (mrq)27.76

Cash flow statement

Operating cash flow (ttm)158.32M
Levered free cash flow (ttm)168.06M